They'll be heading to Phoenix with their families for a few days to meet players, participate in warmups, tour the clubhouse ...

They'll be heading to Phoenix with their families for a few days to meet players, participate in warmups, tour the clubhouse and throw out the first pitch at a spring training game.

Ipsen has suffered a setback in its marathon effort to bring palovarotene to market for ultra rare disease fibrodysplasia ossificans progressiva (FOP), after EU advisors recommended against approval.

Health Canada has given the drug a green light – under the Sohonos brand – to treat fibrodysplasia ossificans progressiva (FOP), making it the first treatment for the ultra-rare genetic disorder.

Jan. 22, 2025 — Following the lead of previous work on mRNA-based vaccines, therapies for spinal cord injuries and more, the method relies upon mineral-coated microparticles to deliver mRNA that ...

EMBO Press encourages applying due care in interpreting bibliometric measures such as CiteScore, h5-Index and Journal Impact Factor among others. EMBO is a foundation signatory of the San Francisco ...

Each journal is staffed by professional editors who work in collaboration with one another and our international Editorial Advisory Boards of leading scientists. Please feel free to contact any of the ...

EMBO Molecular Medicine is an open access online journal published by Wiley-Blackwell on behalf of EMBO. The quality of the journal is guaranteed by the editorial and advisory boards, consisting ...

One of the most significant events during early embryonic development is the establishment of a basic embryonic body plan, which is defined by anteroposterior, dorsoventral (DV), and left-right axes.